OpenVSafe by OpenVAERS
Search V-safe

L2U-84618-33650

3 vaccinations 5 coded responses 6 check-ins 5 free-text entries 3 call cases
Sex
Female
Age at first dose
56-60
ZIP prefix
064 / CT
Registered
2021-03-03
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-03
    Registered in v-safe
  2. 2021-03-03
    Dose 1 — Pfizer-BioNTech
  3. 2021-03-31
    Dose 2 — Pfizer-BioNTech
  4. 2022-01-28
    Dose 3 — Pfizer-BioNTech
  5. 2022-02-10
    Survey response — day 7, dose 3
    MedDRA: Postmenopausal haemorrhage — Feeling: Fair · Site: Pain, Itching · Headache, Joint pains
    Free text: Post menopausal bleeding
    MedDRA releases: 2024-11 · check-in free text available
  6. 2022-02-13
    Survey response — day 14, dose 3
    MedDRA: Postmenopausal haemorrhage — Feeling: Fair
    Free text: Post menopausal bleeding a little worse.
    MedDRA releases: 2024-11 · check-in free text available
  7. 2022-02-18
    Health check-in — day 21, dose 3
    Feeling: Fair
    Adult check-in
  8. 2022-03-04
    Survey response — day 35, dose 3
    MedDRA: Office visit, Postmenopausal haemorrhage — Feeling: Poor · Get care from a doctor or other healthcare professional
    Free text: Symptoms: Post menopausal bleeding · Healthcare visit (other): Dr. Appt
    MedDRA releases: 2024-11 · check-in free text available
  9. 2022-03-04
    Report sent to call center — day 35, dose 3
    Get care from a doctor or other healthcare professional
    1 call case(s)
  10. 2022-03-08
    Call successful
    Reported to VAERS voluntarily prior to GDIT contact
  11. 2022-03-11
    Survey response — day 42, dose 3
    MedDRA: Haemorrhage, Hospitalisation, Surgery — Feeling: Poor · Get care from a doctor or other healthcare professional
    Free text: Symptoms: Still bleeding · Healthcare visit (other): One day surgery-hospital
    MedDRA releases: 2024-11 · check-in free text available
  12. 2022-03-11
    Report sent to call center — day 42, dose 3
    Get care from a doctor or other healthcare professional
    1 call case(s)
  13. 2022-03-14
  14. 2022-04-05
    Call successful
    Reported to VAERS voluntarily prior to GDIT contact
  15. 2022-04-29
    Survey response — 3 months, dose 3
    MedDRA: Haemorrhage, Transfusion, Uterine dilation and curettage — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Still bleeding, had a D and C, but still bleeding, had to get a blood transfusion this week, and will have another D and C on Monday. Bleeding for 80 days
    MedDRA releases: 2024-11 · check-in free text available
  16. 2022-04-29
    Report sent to call center — 3 months, dose 3
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  17. 2022-05-03

Vaccinations

DoseDateManufacturerCo-administered
12021-03-03Pfizer-BioNTech No
22021-03-31Pfizer-BioNTech No
32022-01-28Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2022-03-04 Successful
2022-03-08
Reported to VAERS voluntarily prior to GDIT contact
2022-03-11 Successful
2022-04-05
Reported to VAERS voluntarily prior to GDIT contact
2022-04-29 Unsuccessful

Free text

Release 11 — day 7, dose 3

2022-02-10

Systemic reaction (other): Post menopausal bleeding

Release 11 — day 14, dose 3

2022-02-13

Symptoms: Post menopausal bleeding a little worse.

Release 11 — day 35, dose 3

2022-03-04

Symptoms: Post menopausal bleeding
Healthcare visit (other): Dr. Appt

Release 11 — day 42, dose 3

2022-03-11

Symptoms: Still bleeding
Healthcare visit (other): One day surgery-hospital

Release 11 — 3 months, dose 3

2022-04-29

Symptoms: Still bleeding, had a D and C, but still bleeding, had to get a blood transfusion this week, and will have another D and C on Monday. Bleeding for 80 days

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOHospitalisation · · ✓
HCVOOffice visit · · ✓
HCVOSurgery · · ✓
SDHaemorrhage · · ✓
SDPostmenopausal haemorrhage · · ✓
SDTransfusion · · ✓
SDUterine dilation and curettage · · ✓
SROPostmenopausal haemorrhage · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release